NeuroBio
  • Home
  • About Us
    • Our Science
    • Our Pipeline
    • Neuro-Bio Assets
  • Our People
    • Board
    • Management
    • Science Team
    • Science Advisory Board
    • Company Organogram
  • Publications
  • Investors
    • FAQ’s
  • News
    • Supporters
  • Work With Us
    • Careers
    • Industrial Placements
  • Contact
Select Page
Baroness Greenfield’s Presentation “Societal Challenges to live longer and better” at WeMind Forum in Barcelona – November 2024!

Baroness Greenfield’s Presentation “Societal Challenges to live longer and better” at WeMind Forum in Barcelona – November 2024!

In this fascinating Presentation, Baroness Greenfield delved into how we cope with the challenges of living longer and better in our lives, and why each and every one of us is unique. To watch the full Presentation, click here...
Neuro-Bio new publication – A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice

Neuro-Bio new publication – A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice

Our latest study, published in Neurobiology of Aging, investigates the role of the novel peptide T14 in age-dependent behaviours using female mice models. The findings highlight significant variations in T14 levels with age, shedding light on potential mechanisms...
Baroness Greenfield attends Club Vita Webinar “The Risk of Living Longer S02 E04: Preventing Dementia”

Baroness Greenfield attends Club Vita Webinar “The Risk of Living Longer S02 E04: Preventing Dementia”

Their final episode of season two rounded out the theme of prevention by focusing on an area of significant impact for many of us personally and professionally. Baroness Susan Greenfield (Neuro-Bio Ltd) spoke about and explored the possibilities for preventing...
Baroness Greenfield’s Interview at La Vanguardia – A Spanish Newspaper, based in Barcelona talking about Alzheimer’s Disease

Baroness Greenfield’s Interview at La Vanguardia – A Spanish Newspaper, based in Barcelona talking about Alzheimer’s Disease

“In six months we will have the test for Alzheimer’s, and in two months, the cure!” Baroness Greenfield talks about Alzheimer’s Disease, and the focus on discovering a test and a cure! To read the full interview, with the option to translate,...
Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!

Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!

BLOWING THE MIND, EXPANDING THE MIND & LOSING THE MIND The human brain becomes highly personalized after birth by the development of unique configurations of connections between the brain cells that characterize its subsequent growth, personalizing it into what we...
Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective  Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14...
Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective  Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease

Neuro-Bio new publication – Oxidative Stress Triggers a Pivotal Peptide Linked to Alzheimer’s Disease

Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings...
Neuro-Bio is joining the newly formed Employer Advisory Board at Nottingham Trent University and the Biosciences Department

Neuro-Bio is joining the newly formed Employer Advisory Board at Nottingham Trent University and the Biosciences Department

Sara Garcia Ratés, CSO at Neuro-Bio, will be representing Neuro-Bio together with members of other industries such Big Pharma in this collaboration of academia and industry. The board will provide advice and support to develop the University curriculum, initiate more...
Baroness Greenfield is speaking at the Brain Innovation Day Conference in Brussels – November 2024!

Baroness Greenfield is speaking at the Brain Innovation Day Conference in Brussels – November 2024!

The 4th edition of the Brain Innovation Days, organised by the European Brain Council, will take place on 13-14 November 2024 in Brussels, Belgium. The aim of the event is to bring the wider brain ecosystem together to foster dialogue,...
Baroness Greenfield speaks at the Longevity Nation 2024 Conference – October 2024!

Baroness Greenfield speaks at the Longevity Nation 2024 Conference – October 2024!

Baroness Greenfield spoke online at the Longevity Nation Conference on 28th October 2024, where she spoke about a novel mechanism underlying ageing. Click here to read more about the conference
« Older Entries
Next Entries »

LATEST NEWS

  • Our Office Manager Charles Monro attended the new opening of the reception area at UK Atomic Energy Authority
  • Neuro-Bio welcomes back Adam Khan
  • Charles Munro, our Office Manager attends Culham Campus Quarterly Tenant lunch
  • Neuro-Bio welcomes Amy Lewis
  • New lateral flow test may detect Alzheimer’s decades early! In collaboration with Aptamer Group!

TOPICS

  • Latest News
  • Media

© Neuro-Bio 2025

  • Instagram
© Neuro-Bio 2025